全文获取类型
收费全文 | 10236篇 |
免费 | 693篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 93篇 |
儿科学 | 171篇 |
妇产科学 | 176篇 |
基础医学 | 1396篇 |
口腔科学 | 257篇 |
临床医学 | 948篇 |
内科学 | 2146篇 |
皮肤病学 | 486篇 |
神经病学 | 1212篇 |
特种医学 | 441篇 |
外科学 | 1383篇 |
综合类 | 77篇 |
一般理论 | 14篇 |
预防医学 | 664篇 |
眼科学 | 150篇 |
药学 | 721篇 |
中国医学 | 35篇 |
肿瘤学 | 625篇 |
出版年
2023年 | 51篇 |
2022年 | 45篇 |
2021年 | 230篇 |
2020年 | 173篇 |
2019年 | 223篇 |
2018年 | 240篇 |
2017年 | 189篇 |
2016年 | 226篇 |
2015年 | 267篇 |
2014年 | 362篇 |
2013年 | 476篇 |
2012年 | 718篇 |
2011年 | 748篇 |
2010年 | 438篇 |
2009年 | 414篇 |
2008年 | 686篇 |
2007年 | 714篇 |
2006年 | 647篇 |
2005年 | 610篇 |
2004年 | 546篇 |
2003年 | 457篇 |
2002年 | 436篇 |
2001年 | 144篇 |
2000年 | 136篇 |
1999年 | 133篇 |
1998年 | 108篇 |
1997年 | 91篇 |
1996年 | 58篇 |
1995年 | 62篇 |
1994年 | 41篇 |
1993年 | 55篇 |
1992年 | 63篇 |
1991年 | 71篇 |
1990年 | 64篇 |
1989年 | 73篇 |
1988年 | 67篇 |
1987年 | 65篇 |
1986年 | 64篇 |
1985年 | 52篇 |
1983年 | 42篇 |
1982年 | 37篇 |
1980年 | 30篇 |
1979年 | 40篇 |
1978年 | 33篇 |
1976年 | 38篇 |
1975年 | 37篇 |
1974年 | 35篇 |
1973年 | 32篇 |
1972年 | 32篇 |
1966年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 922 毫秒
1.
2.
3.
Marcel Toussaint Raymond J. Gilles Noura Azzabou Benjamin Marty Alexandre Vignaud Andreas Greiser Pierre G. Carlier 《Medicine》2015,94(43)
Delayed contrast enhancement after injection of a gadolinium-chelate (Gd-chelate) is a reference imaging method to detect myocardial tissue changes. Its localization within the thickness of the myocardial wall allows differentiating various pathological processes such as myocardial infarction (MI), inflammatory myocarditis, and cardiomyopathies. The aim of the study was first to characterize benign myocarditis using quantitative delayed-enhancement imaging and then to investigate whether the measure of the extracellular volume fraction (ECV) can be used to discriminate between MI and myocarditis.In 6 patients with acute benign myocarditis (32.2 ± 13.8 year-old, subepicardial late gadolinium enhancement [LGE]) and 18 patients with MI (52.3 ± 10.9 year-old, subendocardial/transmural LGE), myocardial T1 was determined using the Modified Look-Locker Imaging (MOLLI) sequence at 3 Tesla before and after Gd-chelate injection. T1 values were compared in LGE and normal regions of the myocardium. The myocardial T1 values were normalized to the T1 of blood, and the ECV was calculated from T1 values of myocardium and blood pre- and post-Gd injection.In both myocarditis and MI, the T1 was lower in LGE regions than in normal regions of the left ventricle. T1 of LGE areas was significantly higher in myocarditis than in MI (446.8 ± 45.8 vs 360.5 ± 66.9 ms, P = 0.003) and ECV was lower in myocarditis than in MI (34.5 ± 3.3 vs 53.8 ± 13.0 %, P = 0.004).Both inflammatory process and chronic fibrosis induce LGE (subepicardial in myocarditis and subendocardial in MI). The present study demonstrates that the determination of T1 and ECV is able to differentiate the 2 histological patterns.Further investigation will indicate whether the severity of ECV changes might help refine the predictive risk of LGE in myocarditis. 相似文献
4.
5.
6.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
7.
8.
9.
A. Nast C. Smith P.I. Spuls G. Avila Valle Z. Bata-Csörgö H. Boonen E. De Jong I. Garcia-Doval P. Gisondi D. Kaur-Knudsen S. Mahil T. Mälkönen J.T. Maul S. Mburu U. Mrowietz K. Reich E. Remenyik K.M. Rønholt P.G. Sator M. Schmitt-Egenolf M. Sikora K. Strömer O. Sundnes D. Trigos G. Van Der Kraaij N. Yawalkar C. Dressler 《Journal of the European Academy of Dermatology and Venereology》2020,34(11):2461-2498
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The first part of the guideline includes general information on the scope and purpose, health questions covered, target users and strength/limitations of the guideline. Suggestions for disease severity grading and treatment goals are provided. It presents the general treatment recommendations as well as detailed management and monitoring recommendations for the individual drugs. The treatment options discussed in this guideline are as follows: acitretin, ciclosporin, fumarates, methotrexate, adalimumab, apremilast, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, secukinumab, tildrakizumab and ustekinumab. 相似文献
10.
Jeroen M. van de Pol Jurjen G. Geljon Svetlana V. Belitser Geert W.J. Frederix Anke M. Hövels Marcel L. Bouvy 《Research in social & administrative pharmacy》2019,15(1):70-76